Hara Capital’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.59K Sell
200
-3,856
-95% -$153K ﹤0.01% 254
2026
Q1
$156K Sell
4,056
-11,297
-74% -$466K 0.08% 133
2025
Q4
$631K Hold
15,353
– – 0.35% 70
2025
Q3
$572K Sell
15,353
-360
-2% -$13.1K 0.34% 71
2025
Q2
$573K Sell
15,713
-1,500
-9% -$54.4K 0.36% 62
2025
Q1
$665K Sell
17,213
-4,730
-22% -$188K 0.45% 51
2024
Q4
$832K Buy
+21,943
New +$876K 0.53% 41

Other funds holding BME

Hara Capital's BME Position: Q2 2026 in Review

Hara Capital reduced its BlackRock Health Sciences Trust (BME) stake by 95% in Q2 2026, selling an estimated $153K and leaving 200 shares worth $8.59K. The position accounts for ﹤0.01% of the portfolio, ranked #254.

Hara Capital first reported a position in BME in Q4 2024 and has held it in 7 quarters since. The position peaked at $832K in Q4 2024. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Hara Capital held 200 shares of BlackRock Health Sciences Trust worth $8.59K as of Q2 2026.
  • Hara Capital sold 3,856 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $153K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Hara Capital's portfolio in Q2 2026, its #254 holding.
  • Hara Capital first reported a position in BlackRock Health Sciences Trust in Q4 2024 and has held it in 7 quarters since.
  • Hara Capital's BlackRock Health Sciences Trust position peaked at $832K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.